vialroom

#other-peptides 2026-04-25

Saturday39 messages8 participantstimes are UTC
Highlights from this day
  • dark_for_ten_days — how many weeks is a fair run for GHK-Cu topically 16:16
  • VialBot — Channel stats, last 30 days: 104 messages from 58 members. 17:05
  • same_chromato — oral BPC is a different question from injected and the two get discussed as if theyre the same, ill dig out the number 17:20
  • same_chromato — cold chain matters for anything reconstituted whatever it is, mine live at 4.8 degrees 17:24
  • VialBot — Recon calculator: 10mg in 0.5ml = 10mg/ml. 18:12
SC

coming back to this how long do people run TB-500 before deciding it did nothing

DF

i think most of what gets reported here is regression to the mean, my own reports included

VB

Channel stats, last 30 days: 104 messages from 58 members.

👀8👍18
SC

oral BPC is a different question from injected and the two get discussed as if theyre the same, ill dig out the number

⚠️10

baseline month helped

SC

nobody here can tell you whether BPC will help your injury and anyone who does is guessing

TT

came back after 17 months off and my baseline was where it was before, so nothing persisted

[edited]

right so how do you separate healing from time when the injury was going to heal anyway

is stacking three things at once ever defensible

tesamorelin has a licensed indication and everything outside it is us extrapolating

i log these exactly like doses, date, amount, site, what i noticed, and its still hard to read back

IS

took a full month off everything to get a baseline and it was the most useful month of my log

DD

the verification channel takes these, its just that far fewer people submit them

ran GHK-Cu for 33 weeks and stopped because i couldnt tell, which is a result of a kind

secretagogues made me ravenous, which is a fairly direct signal that something was happening, take that with a pinch of salt

sceptical but curious

SC

i stacked three things for 6 months and the honest conclusion is that i learned nothing

FA

whats the evidence base for tesamorelin outside the licensed indication